Use of phosphatide precursors to promote synaptogenesis.
about
Effects of docosahexaenoic Acid on neurotransmissionThe effect of souvenaid on functional brain network organisation in patients with mild Alzheimer's disease: a randomised controlled studyUsing neurolipidomics to identify phospholipid mediators of synaptic (dys)function in Alzheimer's Disease.Rationale and clinical data supporting nutritional intervention in Alzheimer's disease.Alkemio: association of chemicals with biomedical topics by text and data miningA nutrient combination that can affect synapse formationNutrients required for phospholipid synthesis are lower in blood and cerebrospinal fluid in mild cognitive impairment and Alzheimer's disease dementia.Maternal choline supplementation programs greater activity of the phosphatidylethanolamine N-methyltransferase (PEMT) pathway in adult Ts65Dn trisomic miceNutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses.The efficacy of supplementation with the novel medical food, Souvenaid, in patients with Alzheimer's disease: A systematic review and meta-analysis of randomized clinical trials.Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease.A Dietary Treatment Improves Cerebral Blood Flow and Brain Connectivity in Aging apoE4 MiceAlzheimer's Disease Risk and Progression: The Role of Nutritional Supplements and their Effect on Drug Therapy OutcomeDietary Crude Lecithin Increases Systemic Availability of Dietary Docosahexaenoic Acid with Combined Intake in Rats.Effect Size Analyses of Souvenaid in Patients with Alzheimer's Disease.The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer's disease.Choline and betaine in health and disease.Review: omega-3 and memory function: to eat or not to eat.How Anticholinergic Drugs Might Promote Alzheimer's Disease: More Amyloid-β and Less Phosphatidylcholine.New Perspectives on Alzheimer's Disease and Nutrition.The medical food Souvenaid affects brain phospholipid metabolism in mild Alzheimer's disease: results from a randomized controlled trial.Synaptic Membrane Synthesis in Rats Depends on Dietary Sufficiency of Vitamin C, Vitamin E, and Selenium: Relevance for Alzheimer's Disease.Omega-3 fatty acids, lipids and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention.Ethanolamine and Phosphatidylethanolamine: Partners in Health and Disease.Docosahexaenoic Acid Rescues Synaptogenesis Impairment and Long-Term Memory Deficits Caused by Postnatal Multiple Sevoflurane Exposures.High Content Analysis of Hippocampal Neuron-Astrocyte Co-cultures Shows a Positive Effect of Fortasyn Connect on Neuronal Survival and Postsynaptic Maturation.Promising Effects of Neurorestorative Diets on Motor, Cognitive, and Gastrointestinal Dysfunction after Symptom Development in a Mouse Model of Parkinson's Disease.Oral fish oil restores striatal dopamine release after traumatic brain injury.Design of the NL-ENIGMA study: Exploring the effect of Souvenaid on cerebral glucose metabolism in early Alzheimer's disease.Uridine ameliorates the pathological phenotype in transgenic G93A-ALS mice.Enhancing synaptogenesis in diseases characterized by deficiencies in brain synapses.Souvenaid®: a new approach to management of early Alzheimer's disease.Origin, utilization, and recycling of nucleosides in the central nervous system.A specific multi-nutrient formulation enhances M1 muscarinic acetylcholine receptor responses in vitro.Plasma choline concentration varies with different dietary levels of vitamins B6, B12 and folic acid in rats maintained on choline-adequate diets.Physical Activity, Nutrition, Cognition, Neurophysiology, and Short-Time Synaptic Plasticity in Healthy Older Adults: A Cross-Sectional Study
P2860
Q26996552-DEE75C46-93DF-496F-AE7F-4BF603F1D43BQ28539196-4953263B-2616-4105-93A5-8F21CF5C08FDQ30451918-C5C4B233-8AEA-4718-8182-AE29728165A1Q30779251-0373B722-0A86-44D0-8528-0CABF5C7B13FQ30823348-7DC8BE5C-E792-49A4-9A9C-8F5562106874Q33570506-31349A58-71E7-47A0-B88D-10EB6C7E35F9Q33813927-AAE3D961-FF58-4B93-91D4-42EED6E47013Q34365576-233C28B8-F581-48FE-8AD7-F47D9663184FQ34711683-77C9F863-F538-4686-971E-46250C7342FFQ35861687-A5EB43F3-1EA3-4992-8920-58306D438AEAQ35885375-864D8151-DC13-4A3F-BE71-A33451D0BD80Q36724664-54651431-3977-4126-9E87-40F7B2C53706Q36781717-39ED480E-84AB-44AF-82D2-D3F01D6FB04AQ36994988-230FD693-B9CC-47DD-A230-4E7ED6464256Q37489106-38CF9560-A8C9-4E68-84CB-049A80E11984Q37690572-77518B8E-58BF-43CD-97E2-F15DBB203985Q37743322-C940A36A-8AA7-4A24-90D8-AD8B20CB1294Q37779414-3EA716F4-73CB-4631-A61A-F709B3D8680EQ38592239-34E142A9-6E03-45CB-80E0-183AF9338AECQ38592243-9695C792-77CC-430F-8314-D5FFD9C032B5Q38659608-3E633DFB-5C79-498F-BF80-D9AC3655FA7AQ38734121-893F7345-47B5-4DB7-AC8D-4DE2AECA5433Q39320214-9AE44CC2-1206-49FE-AD09-502AD9AD7E49Q41141822-BF2EF723-E80E-4899-8994-6C78C5856468Q41223236-FFD2C807-96D9-46B6-8E3D-8C6D401134B4Q41243163-F39B503C-07B7-4CA8-86E5-A1D76B0A02F3Q41916365-A431BDCF-D0C8-4B6C-8C71-75550C826E2BQ41965524-C3A67A53-50A5-43A6-8650-B49CC84ABA0AQ42656272-9DE3FC17-335A-49D4-AE29-291D80B51C7EQ42664780-49ABA36B-85A6-4F71-8A0D-50BB12694E13Q42699581-247029DB-727D-4379-8554-F39E8218989AQ43864462-02AD4B2B-B178-4EAB-ADDF-935D4C7C6BFAQ48536160-D9B90DB8-7A16-4A90-8013-A7B983855D38Q50979441-5EB4514C-9D04-43C7-9B60-0B7B32EDD058Q55054883-762C048A-6A6A-4FBB-A1C1-A5AD6756E2CFQ57166669-DF07CD31-DCA9-42B3-9374-6BD6B570C42F
P2860
Use of phosphatide precursors to promote synaptogenesis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Use of phosphatide precursors to promote synaptogenesis.
@ast
Use of phosphatide precursors to promote synaptogenesis.
@en
Use of phosphatide precursors to promote synaptogenesis.
@nl
type
label
Use of phosphatide precursors to promote synaptogenesis.
@ast
Use of phosphatide precursors to promote synaptogenesis.
@en
Use of phosphatide precursors to promote synaptogenesis.
@nl
prefLabel
Use of phosphatide precursors to promote synaptogenesis.
@ast
Use of phosphatide precursors to promote synaptogenesis.
@en
Use of phosphatide precursors to promote synaptogenesis.
@nl
P2093
P1476
Use of phosphatide precursors to promote synaptogenesis
@en
P2093
Ismail H Ulus
Richard J Wurtman
Toshimasa Sakamoto
P356
10.1146/ANNUREV-NUTR-080508-141059
P407
P577
2009-01-01T00:00:00Z